vs
iRhythm Holdings, Inc.(IRTC)与PREFORMED LINE PRODUCTS CO(PLPC)财务数据对比。点击上方公司名可切换其他公司
iRhythm Holdings, Inc.的季度营收约是PREFORMED LINE PRODUCTS CO的1.2倍($208.9M vs $173.1M),PREFORMED LINE PRODUCTS CO净利率更高(4.9% vs 2.7%,领先2.2%),iRhythm Holdings, Inc.同比增速更快(27.1% vs 3.6%),iRhythm Holdings, Inc.自由现金流更多($14.5M vs $11.8M),过去两年iRhythm Holdings, Inc.的营收复合增速更高(25.8% vs 10.8%)
iRhythm Holdings是一家专注于心脏护理领域的数字医疗企业,开发可穿戴动态心脏监测设备及配套AI分析工具,主要服务美国市场的医疗机构与患者,帮助检测房颤等心律异常病症,为临床诊断提供可靠的数据支持。
预成型线路产品公司(PLPC)研发、生产和销售适用于输配电、通信及可再生能源基建领域的工程硬件组件,服务全球多地的公用事业、网络运营商及工业客户,提供可提升网络可靠性与运营效率的解决方案。
IRTC vs PLPC — 直观对比
营收规模更大
IRTC
是对方的1.2倍
$173.1M
营收增速更快
IRTC
高出23.5%
3.6%
净利率更高
PLPC
高出2.2%
2.7%
自由现金流更多
IRTC
多$2.7M
$11.8M
两年增速更快
IRTC
近两年复合增速
10.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $208.9M | $173.1M |
| 净利润 | $5.6M | $8.4M |
| 毛利率 | 70.9% | 29.8% |
| 营业利润率 | 1.1% | 6.8% |
| 净利率 | 2.7% | 4.9% |
| 营收同比 | 27.1% | 3.6% |
| 净利润同比 | 518.5% | -19.3% |
| 每股收益(稀释后) | $0.18 | $1.72 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
IRTC
PLPC
| Q4 25 | $208.9M | $173.1M | ||
| Q3 25 | $192.9M | $178.1M | ||
| Q2 25 | $186.7M | $169.6M | ||
| Q1 25 | $158.7M | $148.5M | ||
| Q4 24 | $164.3M | $167.1M | ||
| Q3 24 | $147.5M | $147.0M | ||
| Q2 24 | $148.0M | $138.7M | ||
| Q1 24 | $131.9M | $140.9M |
净利润
IRTC
PLPC
| Q4 25 | $5.6M | $8.4M | ||
| Q3 25 | $-5.2M | $2.6M | ||
| Q2 25 | $-14.2M | $12.7M | ||
| Q1 25 | $-30.7M | $11.5M | ||
| Q4 24 | $-1.3M | $10.5M | ||
| Q3 24 | $-46.2M | $7.7M | ||
| Q2 24 | $-20.1M | $9.4M | ||
| Q1 24 | $-45.7M | $9.6M |
毛利率
IRTC
PLPC
| Q4 25 | 70.9% | 29.8% | ||
| Q3 25 | 71.1% | 29.7% | ||
| Q2 25 | 71.2% | 32.7% | ||
| Q1 25 | 68.8% | 32.8% | ||
| Q4 24 | 70.0% | 33.3% | ||
| Q3 24 | 68.8% | 31.1% | ||
| Q2 24 | 69.9% | 31.9% | ||
| Q1 24 | 66.3% | 31.3% |
营业利润率
IRTC
PLPC
| Q4 25 | 1.1% | 6.8% | ||
| Q3 25 | -4.4% | 7.4% | ||
| Q2 25 | -10.0% | 10.1% | ||
| Q1 25 | -20.5% | 8.8% | ||
| Q4 24 | -2.5% | 10.5% | ||
| Q3 24 | -34.1% | 7.1% | ||
| Q2 24 | -15.5% | 8.1% | ||
| Q1 24 | -28.9% | 8.2% |
净利率
IRTC
PLPC
| Q4 25 | 2.7% | 4.9% | ||
| Q3 25 | -2.7% | 1.5% | ||
| Q2 25 | -7.6% | 7.5% | ||
| Q1 25 | -19.3% | 7.8% | ||
| Q4 24 | -0.8% | 6.3% | ||
| Q3 24 | -31.3% | 5.2% | ||
| Q2 24 | -13.6% | 6.8% | ||
| Q1 24 | -34.6% | 6.8% |
每股收益(稀释后)
IRTC
PLPC
| Q4 25 | $0.18 | $1.72 | ||
| Q3 25 | $-0.16 | $0.53 | ||
| Q2 25 | $-0.44 | $2.56 | ||
| Q1 25 | $-0.97 | $2.33 | ||
| Q4 24 | $-0.03 | $2.13 | ||
| Q3 24 | $-1.48 | $1.54 | ||
| Q2 24 | $-0.65 | $1.89 | ||
| Q1 24 | $-1.47 | $1.94 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $583.8M | — |
| 总债务越低越好 | — | $38.3M |
| 股东权益账面价值 | $152.7M | $475.5M |
| 总资产 | $1.0B | $653.6M |
| 负债/权益比越低杠杆越低 | — | 0.08× |
8季度趋势,按日历期对齐
现金及短期投资
IRTC
PLPC
| Q4 25 | $583.8M | — | ||
| Q3 25 | $565.2M | — | ||
| Q2 25 | $545.5M | — | ||
| Q1 25 | $520.6M | — | ||
| Q4 24 | $535.6M | — | ||
| Q3 24 | $522.0M | — | ||
| Q2 24 | $561.5M | — | ||
| Q1 24 | $569.1M | — |
总债务
IRTC
PLPC
| Q4 25 | — | $38.3M | ||
| Q3 25 | — | $36.0M | ||
| Q2 25 | — | $31.8M | ||
| Q1 25 | — | $29.1M | ||
| Q4 24 | — | $20.8M | ||
| Q3 24 | — | $27.2M | ||
| Q2 24 | — | $31.6M | ||
| Q1 24 | — | $55.0M |
股东权益
IRTC
PLPC
| Q4 25 | $152.7M | $475.5M | ||
| Q3 25 | $121.9M | $466.3M | ||
| Q2 25 | $103.7M | $460.7M | ||
| Q1 25 | $86.7M | $435.8M | ||
| Q4 24 | $90.9M | $422.3M | ||
| Q3 24 | $71.8M | $429.0M | ||
| Q2 24 | $99.2M | $416.2M | ||
| Q1 24 | $90.3M | $413.4M |
总资产
IRTC
PLPC
| Q4 25 | $1.0B | $653.6M | ||
| Q3 25 | $995.2M | $644.6M | ||
| Q2 25 | $964.0M | $631.5M | ||
| Q1 25 | $926.1M | $592.5M | ||
| Q4 24 | $931.4M | $573.9M | ||
| Q3 24 | $909.7M | $592.0M | ||
| Q2 24 | $919.2M | $572.6M | ||
| Q1 24 | $909.8M | $586.1M |
负债/权益比
IRTC
PLPC
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.08× | ||
| Q2 25 | — | 0.07× | ||
| Q1 25 | — | 0.07× | ||
| Q4 24 | — | 0.05× | ||
| Q3 24 | — | 0.06× | ||
| Q2 24 | — | 0.08× | ||
| Q1 24 | — | 0.13× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $26.2M | $21.9M |
| 自由现金流经营现金流 - 资本支出 | $14.5M | $11.8M |
| 自由现金流率自由现金流/营收 | 6.9% | 6.8% |
| 资本支出强度资本支出/营收 | 5.6% | 5.9% |
| 现金转化率经营现金流/净利润 | 4.70× | 2.60× |
| 过去12个月自由现金流最近4个季度 | $34.5M | $33.3M |
8季度趋势,按日历期对齐
经营现金流
IRTC
PLPC
| Q4 25 | $26.2M | $21.9M | ||
| Q3 25 | $34.9M | $18.9M | ||
| Q2 25 | $27.7M | $26.9M | ||
| Q1 25 | $-7.9M | $5.7M | ||
| Q4 24 | $19.2M | $24.1M | ||
| Q3 24 | $24.3M | $9.4M | ||
| Q2 24 | $11.8M | $28.3M | ||
| Q1 24 | $-52.0M | $5.8M |
自由现金流
IRTC
PLPC
| Q4 25 | $14.5M | $11.8M | ||
| Q3 25 | $20.1M | $8.3M | ||
| Q2 25 | $17.3M | $18.6M | ||
| Q1 25 | $-17.3M | $-5.3M | ||
| Q4 24 | $12.4M | $20.6M | ||
| Q3 24 | $15.5M | $5.8M | ||
| Q2 24 | $3.4M | $24.6M | ||
| Q1 24 | $-61.8M | $1.8M |
自由现金流率
IRTC
PLPC
| Q4 25 | 6.9% | 6.8% | ||
| Q3 25 | 10.4% | 4.7% | ||
| Q2 25 | 9.3% | 10.9% | ||
| Q1 25 | -10.9% | -3.6% | ||
| Q4 24 | 7.5% | 12.3% | ||
| Q3 24 | 10.5% | 3.9% | ||
| Q2 24 | 2.3% | 17.7% | ||
| Q1 24 | -46.8% | 1.3% |
资本支出强度
IRTC
PLPC
| Q4 25 | 5.6% | 5.9% | ||
| Q3 25 | 7.7% | 6.0% | ||
| Q2 25 | 5.6% | 4.9% | ||
| Q1 25 | 5.9% | 7.4% | ||
| Q4 24 | 4.2% | 2.1% | ||
| Q3 24 | 6.0% | 2.4% | ||
| Q2 24 | 5.7% | 2.7% | ||
| Q1 24 | 7.4% | 2.8% |
现金转化率
IRTC
PLPC
| Q4 25 | 4.70× | 2.60× | ||
| Q3 25 | — | 7.21× | ||
| Q2 25 | — | 2.12× | ||
| Q1 25 | — | 0.49× | ||
| Q4 24 | — | 2.30× | ||
| Q3 24 | — | 1.22× | ||
| Q2 24 | — | 3.02× | ||
| Q1 24 | — | 0.60× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IRTC
| Commercial Payors | $111.7M | 53% |
| Centers For Medicare And Medicaid | $49.2M | 24% |
| Healthcare Institutions | $34.3M | 16% |
| Non Contracted Third Party Payors | $13.7M | 7% |
PLPC
暂无分部数据